QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 19 August 2020Portfolio NewsCentauri Health Solutions Announces Acquisition of HCFS
- 12 August 2020Portfolio NewsCentauri Health Solutions Ranks No. 448 on the 2020 Inc. 5000 List of America’s Fastest-Growing Private Companies
- 11 August 2020Portfolio NewsBicycle Therapeutics Appoints Dr. Dominic Smethurst as Chief Medical Officer
- 10 August 2020SV NewsSV Health Investors discuss the firm’s new $90M early-stage Medtech Convergence Fund
- 4 August 2020Portfolio NewsRibometrix Further Expands Leadership with Appointment of Barclay "Buck" Phillips as Chief Operating Officer and Chief Financial Officer
- 4 August 2020Portfolio NewsCentauri Health Solutions Adds New Analytics Capabilities with Acquisition of AppRev
- 4 August 2020Portfolio NewsCatabasis Pharmaceuticals and Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive and Drug-Resistant Tuberculosis
- 23 July 2020Portfolio NewsXilio Therapeutics Appoints Paul J. Clancy to its Board of Directors
- 22 July 2020Portfolio NewsExcellent news today from our portfolio company @Cerevance on the expansion of its Series B financing round, adding a further $20 million to the $45 million announced in April.
- 21 July 2020Portfolio NewsHealthify Partners with Ride Health to Provide Non-Medical Transportation Services to People in Need
- 20 July 2020SV NewsBritish Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies
- 20 July 2020SV NewsSV Health Investors hits $265m final close for first dedicated biotech fundraise